The activation-induced cytidine deaminase (AID; also known as AICDA) enzyme is required for somatic hypermutation and class switch recombination at the immunoglobulin locus 1 . In germinalcentre B cells, AID is highly expressed, and has an inherent mutator activity that helps generate antibody diversity 2 . However, AID may also regulate gene expression epigenetically by directly deaminating 5-methylcytosine in concert with base-excision repair to exchange cytosine 3 . This pathway promotes gene demethylation, thereby removing epigenetic memory. For example, AID promotes active demethylation of the genome in primordial germ cells 4 . However, different studies have suggested either a requirement 5 or a lack of function 6 for AID in promoting pluripotency in somatic nuclei after fusion with embryonic stem cells. Here we tested directly whether AID regulates epigenetic memory by comparing the relative ability of cells lacking AID to reprogram from a differentiated murine cell type to an induced pluripotent stem cell. We show that Aid-null cells are transiently hyper-responsive to the reprogramming process. Although they initiate expression of pluripotency genes, they fail to stabilize in the pluripotent state. The genome of Aid-null cells remains hypermethylated in reprogramming cells, and hypermethylated genes associated with pluripotency fail to be stably upregulated, including many MYC target genes. Recent studies identified a late step of reprogramming associated with methylation status 7 , and implicated a secondary set of pluripotency network components 8 . AID regulates this late step, removing epigenetic memory to stabilize the pluripotent state.
The path to pluripotency involves multiple steps that can be more or less efficient, and this can be modelled in transcription-factor-induced reprogramming 9 . Reprogrammed induced pluripotent stem cell (iPSC) clones initially retain methylation patterns that may reflect an epigenetic memory of the source lineage 10, 11 . To test directly the function of AID in reprogramming, we prepared tail-tip fibroblasts (TTFs) from Aid-knockout or control sibling mice. Before reprogramming, the fibroblasts appeared morphologically identical ( Supplementary Fig. 1a ), and were transduced equivalently with lentivirus encoding the four human 'Yamanaka' reprogramming transcription factors 12 : OCT4, KLF4, SOX2 and cMYC (OKSM; Supplementary Fig. 1b ). Expression levels of exogenous human OCT4 72 h after infection (before induction of the endogenous murine gene) were equivalent, showing that lack of AID does not affect expression vector function ( Supplementary Fig. 1c ). Exogenous transcription factor expression was subsequently equivalently repressed in wild-type and Aid-null transduced cells ( Supplementary Fig. 1d ). Using quantitative polymerase chain reaction with reverse transcription (RT-qPCR) assays, transcript levels for Aid were not reliably detected above background in wild-type TTFs. However, after 1 week of reprogramming, transcripts were readily measured in wild-type cells, increasing as much as tenfold during the reprogramming process ( Supplementary  Fig. 2 ).
Initial reprogramming steps include the induction of proliferation and a change in the morphology of fibroblasts to smaller and rounder cells 13 . We found that cells lacking AID are initially hyper-responsive to reprogramming factors. The change in morphology was more rapid in Aid 2/2 cells, beginning at 2 days after transduction. After 4 days, Aid 2/2 cells were rounded and smaller than Aid 1/1 cells ( Fig. 1a) . A higher fraction of Aid 2/2 cells stained positive for SSEA1, an early marker for pluripotency 14 (Fig. 1b) . At day 7, more Aid-null cells expressed NANOG compared with controls ( Fig. 1c ), correlating with modestly higher transcript levels for several pluripotency genes before the first week of reprogramming ( Fig. 1d ). Consistent with the molecular data, at 2 weeks the Aid-null cells consistently generated more early colonies than wild-type cells (sixfold more colonies on average over six independent experiments). Thus, Aid-null fibroblasts are hyper-responsive to reprogramming, even though the growth curves for uninfected wildtype and Aid-null cells were indistinguishable ( Supplementary Fig. 3a ). Rather, the enhanced expression of pluripotency markers in Aid 2/2 cells suggests that AID normally helps to stabilize the differentiated state, creating a barrier to the initial process of reprogramming. When the Aid 2/2 fibroblasts were passaged before transduction, this hyperresponsiveness was no longer seen ( Supplementary Fig. 3b ), suggesting that passive removal of epigenetic marks through DNA replication can normalize the initial response to OKSM. Although there were more cells, no obvious differences were observed at 2 weeks in the morphologies of iPSC-like colonies derived from Aid 2/2 cells compared with Aid 1/1 cells, and both stained positive for the pluripotency marker NANOG ( Supplementary Fig. 4 ). However, by 4 weeks the colonies derived from Aid 2/2 fibroblasts were flattened with less defined edges ( Fig. 2a ). We tracked individual iPSC-like colonies and observed many Aid 2/2 colonies that appeared pluripotent at 3 weeks but showed a differentiated morphology at 4 weeks ( Fig. 2b) . At 3 weeks, the Aid 2/2 colonies showed a 'patchy' NANOG pattern, and by 4 weeks most colonies were differentiated, with few NANOG 1 cells (Fig. 2c ). This highly reproducible phenomenon was never observed for colonies derived from Aid 1/1 cells, which retained their iPSC morphology and NANOG expression throughout the 4 weeks ( Fig. 2b, c) . The colonies derived from Aid 2/2 cells showed a progressive decline in the frequency of cells expressing SSEA1 ( Fig. 2d ) and OCT4 ( Fig. 2e ). The same results were observed using mouse embryonic fibroblasts (MEFs), as the Aid-null cells failed to maintain a pluripotent iPSC phenotype ( Supplementary Fig. 5 ). The stabilization of pluripotency was equally effective in wild-type cells (and ineffective in Aid-null cells) regardless of whether constitutively expressed or doxycycline-inducible OSKM cassettes were used (Supplementary Fig. 6a ).
Using either wild-type or Aid-null cells, the expression of OKSM using a doxycycline-inducible vector for only 6 days was insufficient to generate pluripotent colonies. OKSM expression for 9, 12, 21 or 28 days was sufficient to generate pluripotent colonies, showing a 'dose response' in the wild-type fibroblasts, but was equally ineffective for generating stable pluripotent cells from Aid-null cells at the 4-week time point ( Supplementary Fig. 6b , c). When AID was expressed along with OKSM during initial reprogramming stages, this failed to rescue pluripotency (data not shown). However, when OKSM-transduced Aidnull cells were secondarily infected with an AID-expressing retrovirus after 1 week ( Supplementary Fig. 7a, b ), there was a partial but statistically significant rescue of pluripotency markers stabilized at the 4-week time point. Because the rescue was not complete we cannot rule out additional molecular mechanisms, beyond AID, that also contribute to the stabilization of pluripotency. Expression of AID in wild-type cells further enhanced the stable expression of pluripotency markers at 4 weeks ( Supplementary Fig. 7c ). As Nanog is syntenic with the Aid locus, an independent set of experiments used fibroblasts derived from an Aidknockout strain in which the neoR gene was deleted 15 . These 'clean' knockout cells also failed to derive stable iPSC colonies (data not shown).
It was previously reported that iPSCs derived from different cell types retain an epigenetic memory of their somatic phenotype 10, 11 . We tested whether genome replication through passaging could stabilize a pluripotent phenotype even in the absence of AID. We generated iPSC-like colonies and isolated 13 Aid 1/1 and 12 Aid 2/2 colonies (clones) at 3 weeks that appeared pluripotent by morphology. After three passages (p3) all the clones, regardless of genotype, retained iPSClike morphology and stained positive for OCT4 and NANOG ( Fig. 3a ). However, between p7 and p10, 5 out of 12 Aid 2/2 clones failed to retain pluripotency and differentiated ( Fig. 3b ). All 13 Aid 1/1 colonies and the other 7 Aid 2/2 clones that were stable beyond p10 retained pluripotency until at least p50. All iPSC clones that retained morphology beyond p10 formed embryoid bodies equivalently and could differentiate into cells expressing smooth muscle actin (mesoderm), bIII tubulin (ectoderm) and a-fetoprotein (endoderm), regardless of Aid genotype ( Fig. 3c ). In an independent set of experiments, wild-type and Aid-null clones were picked and either maintained in culture as colonies or passaged. The non-passaged wild-type-derived clones maintained a pluripotent morphology, whereas the Aid-null cells differentiated. With passaging, 60% of the Aid-null clones were able to maintain a pluripotent morphology ( Supplementary Fig. 8 ).
Thus, although AID is not essential for reprogramming, an important transition occurs at around 3 weeks that is assisted by AID to stabilize the pluripotent phenotype. We considered whether the previously described DNA-demethylating role of AID might be at least partially responsible for this phenotypic stabilization. We profiled the epigenome by carrying out reduced-representation bisulphite sequencing (RRBS) in Aid-null and control cells after 3 weeks of pluripotent. a, b, Immunostaining of iPSC colonies isolated 3 weeks after OKSM transduction and passaged three times (a) or seven times (b) before staining. In this example, the null cells failed to from stable iPSCs. c, Stable iPSC clones were passaged more than ten times. In this case (unlike in b) the passaged Aid-null cells maintained NANOG expression (data not shown) and generate embryoid bodies (EBs) that differentiate into cells positive for smooth muscle actin (SMA), bIII tubulin (bIII TUB) and a-fetoprotein (AFP). Original magnification, 310.
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reprogramming. We observed global DNA hypermethylation in the Aid-null cells ( Supplementary Fig. 9a ), when we considered either total CpGs or differentially methylated regions (DMRs). DNA hypermethylation occurs preferentially near RGYW motifs ( Supplementary Fig. 9b ), the characteristic DNA-targeting sites for AID (45% of the hypermethylated CpGs). Notably, as AID targets gene bodies, the hypermethylated regions are enriched in gene bodies, even though RRBS is biased towards capturing CpG-rich promoter and enhancer regions ( Supplementary  Fig. 9c ).
Transcript profiles comparing the original, pre-transduced fibroblasts from Aid 1/1 and Aid 2/2 embryos closely match (Supplementary Fig. 10a ). By contrast, many genes fail to be upregulated in the mutant cells during reprogramming (Fig. 4a, b and Supplementary  Fig. 10b ). The genes that fail to be upregulated during reprogramming are highly enriched (P , 1 3 10 210 ) in the gene set showing hypermethylation in Aid-null cells ( Fig. 4c ). Of note, genes that are upregulated during reprogramming in both wild-type and Aid-null cells are also enriched in hypermethylated genes (P , 1 3 10 214 ), suggesting that many genes overcome the loss of AID during reprogramming. Among the set of hypermethylated genes, in Aid-null cells there is a failure to upregulate a set of secondary pluripotency genes, including Rex1 (also known as Zfp42), Gdf3, Dnmt3l, Cbx7, Zfp296, Dnmt1, Apobec1 and Tet3 (Fig. 4d ). This expression data correlates well with the RBBS data, which was validated by MassArray bisulphite sequencing ( Supplementary Fig. 11 ), and is consistent with a failure of this downstream network to be demethylated at late stages of reprogramming. Comparing the gene set of hypermethylated underexpressed genes to public embryonic stem (ES)-cell chromatin immunoprecipitation and massively parallel DNA sequencing (ChIP-seq) data sets revealed a marked enrichment of cMYC target genes in reprogramming cells lacking AID ( Supplementary Fig. 12 ). According to qPCR data there was no difference in cMyc transcript levels in wild-type or Aid-null cells at any point in the reprogramming process (data not shown). Furthermore, enhanced levels of cMYC, achieved by retroviral transduction starting at 1 week of reprogramming, failed to stabilize pluripotency in Aid-null cells ( Supplementary Fig. 13 ), suggesting that cMYC access to key target pluripotency genes (due to hypermethylation) rather than cMYC levels per se may be a limiting step for stabilization of the network.
Individual iPSC-like clones were isolated at 2 weeks and expanded to evaluate global methylation patterns for each individual clone. Hypermethylation patterns in the Aid-null clones were highly consistent with data obtained from bulk colony analysis. On the basis of genome-wide DNA methylation profiles (with the genome binned for 100 kb regions), Aid-null or wild-type clones cluster according to genotype ( Supplementary Fig. 14a ). Regions that were hypermethylated in the Aid-null bulk analysis tended to be hypermethylated in the Aid-null clones ( Supplementary Fig. 14b ). In fact, 66% of bulk hypermethylated DMRs were also hypermethylated in DNA derived from the isolated clones (P , 1 3 10 2151 ). Methylation differences found previously for the secondary pluripotency genes were largely validated by MassArray bisulphite sequencing of DNA ( Supplementary Fig.  14c ), and most of the hypermethylated genes were expressed in the Aid-null clones at significantly lower levels compared with levels in wild-type clones ( Supplementary Fig. 14d ).
Altogether, our results show that active demethylation through AID-dependent cytosine deamination is important for stabilizing a genetic network controlling stem-cell phenotype. AID is not essential for reprogramming, because cells lacking AID can form stable pluripotent iPSCs, either through a passive demethylation process facilitated by DNA replication, or perhaps through compensation from related members of the APOBEC family 16 . A recent study suggested that loss of AID affects transcription-factor-induced reprogramming only by an early acute short hairpin RNA (shRNA)-dependent depletion 17 , but did not report the 'iPSC' phenotype beyond 3 weeks, when we show that Aid-null cells eventually fail to stabilize as pluripotent. Unless passaged, Aid-null cells always fail to reprogram. RNA-seq profiles of Aid-null cells after 4 weeks of reprogramming cluster with fibroblast samples (data not shown), and qPCR analysis validates significant upregulation of fibroblast-associated genes in the Aid-null samples ( Supplementary Fig. 15 ), consistent with an epigenetic memory for fibroblast fate that fails to be fully removed during reprogramming in 
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the absence of AID. The function of AID for transition to a stable pluripotent phenotype may be relevant during embryogenesis, as Aidknockout strains have small litters. We found that ES-cell lines could be established from Aid-null blastocysts, and these appeared by morphology and staining patterns to be normal ( Supplementary Fig. 16 ). However, the efficiency of ES-cell-line derivation was markedly reduced (17/28 embryos, 60.7%) compared with congenic wild-type embryos (21/24, 87.5%; P , 0.03 by chi-squared analysis). Although there is much promise for the use of iPSCs for disease modelling and cellular therapies 18 , there remains concern about whether iPSC genomes are damaged through the process of reprogramming [19] [20] [21] . AID, which has natural mutator activity, is activated during reprogramming, and mediates demethylation in gene bodies including secondary pluripotency genes that encode proto-oncogenes. Although inefficient, we showed that iPSCs could be generated in the absence of AID, removing epigenetic memory marks through an AID-independent mechanism. Retaining epigenetic memory, in the absence of AID, might be useful for promoting efficiency of differentiation towards parental lineage fate. Furthermore, if AID-independent reprogramming lessens the mutation load, it could provide a safer strategy for the generation of iPSCs for cellular therapies.
METHODS SUMMARY
TTFs were prepared using 0.2% collagenase; MEFs were prepared from embryonic day (E)13.5 embryos. Intracellular immunostaining was performed after fixing the cells with 4% paraformaldehyde. Surface staining was done without fixing the cells. Complementary DNA was prepared using Superscript III and qPCR was performed (primers listed in Supplementary Table 1 ) using SYBR green and a Roche LightCycler 480 II. All data were from at least three independent experiments. Enhanced RRBS was performed as described 22 and bisulphite reads were aligned to the bisulphite-converted mm9 genome using Bismark 23 . We achieved very high coverage by sequencing one full Illumina lane (,200 M, 51 bp reads) per sample. For bulk colonies, the wild-type and Aid-null samples (at 3 weeks) were analysed with RRBS that covered 1.96 M and 1.82 M CpGs, respectively, with at least 103 coverage (with .1.62 M CpGs in common between the two runs). 1.52 M and 1.59 M CpGs had $203 coverage in wild-type and Aid 2/2 cells, respectively. 1.17 M and 1.32 M CpGs had $503 coverage, respectively. Differentially methylated CpGs were identified using the Fisher exact test with Benjamini-Hochberg correction for multiple testing. DMRs were defined as containing at least five differentially methylated CpGs and a total methylation difference of more than 10%. Paired-end RNA-seq libraries were constructed as described 24 and sequenced using an Illumina HiSeq2000. Reads were aligned to mm9 using TopHat and gene expression levels were quantified using Cufflinks, using upper-quartile and GC-content normalizations. Fold changes of 1.5 with fragments per kilobase of transcript per million fragments mapped (FPKM) .5 in at least one condition were used to derive differentially expressed genes. MassArray EpiTYPER analysis was performed on selected regions identified as hypermethylated by RRBS. PCR primers (Supplementary Table 2 ) were designed to probe amplicons using EpiDesigner (http://www.epidesigner.com/). Bisulphite conversion and MassArray analysis were performed as previously described 22 . Metadata for all RRBS experiments are given in Supplementary  Table 3 . Methylation differences were calculated at each CpG and boxplot analysis was performed at each interrogated region. All statistical analyses were performed using the R software package.
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Summary. Intracellular immunostaining was performed after fixing the cells with 4% paraformaldehyde. Surface staining was done without fixing the cells. All data were from at least three independent experiments. Enhanced RRBS was performed as described 22 and bisulphite reads were aligned to the bisulphite-converted mm9 genome using Bismark 23 . We achieved very high coverage by sequencing one full Illumina lane (,200 M, 51 bp reads) per sample. For bulk colonies, the wild-type and Aid-null samples (at 3 weeks) were analysed with RRBS that covered 1.96 M and 1.82 M CpGs, respectively, with at least 103 coverage (with .1.62 M CpGs in common between the two runs). 1.52 M and 1.59 M CpGs had $203 coverage in wild-type and Aid 2/2 cells, respectively. 1.17 M and 1.32 M CpGs had $503 coverage, respectively. Differentially methylated CpGs were identified using the Fisher exact test with Benjamini-Hochberg correction for multiple testing. DMRs were defined as containing at least five differentially methylated CpGs and a total methylation difference of more than 10%. Paired-end RNA-seq libraries were constructed as described 24 and sequenced using an Illumina HiSeq2000. Mass-Array EpiTYPER analysis was performed on selected regions identified as hypermethylated by RRBS. PCR primers (Supplementary Table 2 ) were designed to probe amplicons using EpiDesigner (http://www.epidesigner.com/). Bisulphite conversion and MassArray analysis were performed as previously described 22 . Metadata for all RRBS experiments are given in Supplementary Table 3 . Methylation differences were calculated at each CpG and boxplot analysis was performed at each interrogated region. All statistical analyses were performed using the R software package. Mice. AID-deficient (Aid 2/2 ) mice were a gift from T. Honjo. Some of the reprogramming experiments were performed on the Aid 2/2 and Aid 1/1 littermates derived by crossing Aid 1/2 mice, and for some of the experiments wild-type BALB/c mice were purchased from the Jackson Laboratory. Reprogramming experiments were performed on tail fibroblasts obtained from seven Aid 2/2 and seven Aid 1/1 age-matched mice (four littermates and three non-littermates, each). We observed similar results when comparing littermates or the purchased mice. Mice or embryos used for MEFs were genotyped by PCR. All animals were maintained according to the guidelines for animal welfare of the Memorial Sloan-Kettering Research Animal Resource Center. Preparation of fibroblasts. For preparation of tail fibroblasts either whole tails or tail tips were collected from age-matched adult Aid 1/1 and Aid 2/2 mice (age range, 3-8 weeks). Tails or tail tips were minced using a razor blade/scalpel after washing with PBS. For preparation of MEFs, Aid 1/2 males and Aid 1/2 females were time mated and E13.5 embryos were collected. Embryos were washed several times and extra care was taken to prevent maternal cross contamination. After removing the head and all internal organs embryos were minced using a razor blade/scalpel. Minced tails or embryos were washed twice with DMEM (Cellgro) containing 10% FBS (Gemini Bio Products), 1 mM L-glutamine (Cellgro), 100 U ml 21 penicillin (Cellgro) and 10 mg ml 21 streptomycin (Cellgro), and dissociated using 0.2% collagenase from Clostridium histolyticum (Sigma) at 37 uC for 4 h (tails) or 2 h (embryos) with continuous shaking. Dissociated cells were filtered through a 70-mm cell strainer (BD falcon) and washed two times with DMEM containing 10% FBS and plated on 0.1% gelatin-(Cellgro) coated tissue culture plates. Fibroblasts were cultured in DMEM containing 10% FBS, 1 mM L-glutamine, 100 U ml 21 penicillin and 100 mg ml 21 streptomycin and media was replaced daily. After passaging two times, fibroblasts were frozen in media containing 10% DMSO, 40% FBS and 50% DMEM. Generally, p2 fibroblasts were used for the reprogramming experiments, unless indicated otherwise. Genotype was confirmed by PCR. Primers for wild type, F: 59-GGTCCCAGTCTGAGATGTA; R: 59-CAACGTGGCGTCCAAACAGGC; for knockout, F: 59-CTGCCAAACCTGA TGTCTTGA; R: 59-AACCAAGCCTATGCCTACAGC. Production of lentiviruses and retroviruses. Reprogramming virus was produced by transfection of a single lentiviral stem cell cassette (STEMCCA) in HEK293T cells using polyethylenimine (PEI) (Polysciences). STEMCCA (constitutive) expresses all four human factors (OCT4, KLF4, SOX2, cMYC), using a single elongation factor 1a (EF1a) promoter within a lentiviral vector using a combination of 2A peptide and internal ribosome entry site (IRES) strategies. Both constitutive and doxycycline-inducible STEMCCA vectors were used for the reprogramming studies. For the doxycycline-inducible system, fibroblasts were treated with doxycycline (1 mg ml 21 ) starting 1 day after transduction for 2 weeks. Lentiviruses were produced using a five-plasmid transfection system with STEMCCA transfected together with four expression vectors encoding the packaging proteins Gag-Pol, Rev and Tat, and the G protein of the vesicular stomatitis virus (VSV). Five vectors were incubated in DMEM with 0.06% PEI for 20 min and then transferred to the plates containing 80% confluent HEK293T cells. Transfection was performed in FBS (10%) containing media. After 5 h media was replaced with fresh media. Viral supernatant was collected after 48 h and spun at 3,000 r.p.m. to remove dead cells and filtered through a sterile syringe filter with 0.45 mm polyethersulfone membrane (VWR international). Ectopic expression of wild-type AID or catalytically mutant AID was achieved using retroviral vectors as described previously 25 . Retroviruses were produced by co-transfecting the vector with the packaging plasmid pCL-ECO in HEK293T cells. The cMYC overexpression experiments were achieved using retroviral vector pMXs-c-Myc (Addgene, 13375). pMXs-c-Myc was co-transfected with vector encoding VSVg in GP2-293 cells to collect functional virus. Transduction with lentiviruses. Five-hundred-thousand fibroblasts were plated in one well of a gelatin-coated 6-well tissue culture plate. After 6 h, 1 ml of viral supernatant containing 8 mg ml 21 polybrene (Millipore) was added to the fibroblast-containing wells. For every experiment, Aid 2/2 and Aid 1/1 fibroblasts were infected at the same time with an identical titre of virus, prepared for each experiment from the same batch. Viral supernatant was removed after 12 h of infection and fresh media containing DMEM, 10% FBS, 1 mM L-glutamine, 100 U ml 21 penicillin and 10 mg ml 21 streptomycin was added. After 1 day media was replaced by mouse embryonic stem-cell (MES) media containing DMEM, 20% ES-cellcompatible FBS (Gemini Bio Products), LIF (2% conditioned medium) and 1.5 3 10 24 M monothioglycerol (MTG; Sigma), 1 mM L-glutamine, 100 U ml 21 penicillin and 10 mg ml 21 streptomycin. Cells were maintained in the same media. In some of the experiments cells were transferred to mitotically inactivated MEF feeders after 2 days of transduction. Approximately 30,000-50,000 cells were transferred to one well of a feeder-containing 6-well plate. Isolated iPSC colonies were always cultured on feeders. All the cells were kept at 37 uC in a humidified environment at 5% CO 2 .
Immunostaining. Immunostaining was performed on fixed cells (4% PFA in BBS with 1 mM CaCl 2 , 15 min) washed and blocked for 30 min in BBT-BSA buffer (BBS with 0.5% BSA, 0.1% Triton and 1 mM CaCl 2 ). Cells with primary antibodies were incubated overnight at 4 uC at the following dilutions: anti-NANOG (eBiosciences 14-5761, 1:100, 5 mg ml 21 ) and anti-OCT4 (Santa Cruz 5279, 1:100, 2 mg ml 21 ). Cells were washed and blocked in BBT-BSA and then incubated with Alexa-conjugated secondary antibodies (1:500, from Molecular Probes). Vectashield-DAPI was used as a mounting medium. Images were acquired using a Zeiss LSM 510-Meta confocal microscope or a Zeiss epifluorescence microscope with AxioVision software. For flow cytometric analysis cells were trypsinized, fixed with 4% PFA for 20 min, blocked for 1 h and then stained in suspension. SSEA1 (Santa Cruz, 1:100) staining was performed on unfixed cells. Cells were analysed on a BD-Accuri C6 flow cytometer (BD Biosciences) using CFlow Plus software. RT-qPCR. Cells were trypsinized and collected in Trizol reagent (Life technologies). Total RNA extraction was done using the RNeasy Mini Kit (Qiagen). The cDNA was synthesized using the SuperScript III First-Strand Synthesis System (Invitrogen). RT-qPCR was performed on three experimental replicates using SYBR green Master I (Roche). Data were generated on a LightCycler 480 II (Roche) and analysed using LightCycler 480 software. qPCR data was calculated based on the mean of three experimental replicates. All quantifications were normalized to an endogenous Gapdh control. The relative quantification value for each target gene was compared to the calibrator for that target gene. All the primers used for qPCR spanned introns (Supplementary Table 1 ). In vitro differentiation. For embryoid body formation, iPSCs were passaged two times on feeder-free gelatin-coated culture dishes. 5 3 10 5 iPSCs were plated on a 10-cm low attachment dish. Embryoid bodies were cultured for 6 days in MES media without LIF, and media was changed every other day. For mesodermal differentiation, embryoid bodies were replated on gelatin-coated dishes and cultured for another 7 days in the same media. For neural differentiation, embryoid bodies were cultured in media containing DMEM F-12 (Cellgro), 0.5% N2 (Gibco) and 0.5% B27 (Gibco) supplements, 1 mM L-glutamine, 1% non-essential amino acids (Gibco) and 1.5 3 10 24 M monothioglycerol for another 3 days, after which embryoid bodies were seeded onto gelatin-coated dishes with the same media, plus 10 mM retinoic acid (Sigma) for another 4 days. For endoderm differentiation, embryoid bodies were replated onto gelatin-coated dishes in MES media lacking LIF but containing 0.5% FBS and 50 ng ml 21 Activin (R&D) for 7 days. For all differentiation cultures, media was changed daily. ES-cell derivation from blastcyst-stage mouse embryos. Aid 2/2 males and Aid 2/2 females (or congenic wild-type pairs as controls) were time mated and E3.5 blastocyst-staged embryos were collected in M2 media according to standard protocols 26 . Embryos were placed on mitotically inactivated MEFs 27 in knockout DMEM (Gibco) containing 15% knockout serum replacement (KSR; Gibco), 2 mM L-glutamine, 0.1 mM b-mercaptoethanol, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 100 U ml 21 penicillin and 100 mg ml 21 streptomycin, 1,000 U ml 21 LIF, 1 mM PD0325901 (ERK inhibitor) and 3 mM CHIR99021 (inhibitor of GSK3B). After embryos attached, media was replaced every other day. After 10-11 days an outgrowth could be observed and was dissociated in 0.25% trypsin/EDTA using a mouth-controlled drawn glass pipette. Trypsin was inactivated by adding knockout LETTER RESEARCH DMEM (Gibco) containing 15% ES-cell-compatible FBS, 2 mM L-glutamine, 0.1 mM b-mercaptoethanol, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 100 U ml 21 penicillin and 100 mg ml 21 streptomycin, 1,000 U ml 21 LIF, 1 mM PD0325901 and 3 mM CHIR99021. From this point onwards the culture was maintained in the same media on mitotically inactivated MEFs. Media was replaced every other day. After 3-5 days ES-cell-like colonies were observed and passaged at 70% confluency. Stable ES-cell lines were validated by passaging a minimum of ten times without loss of pluripotent morphology or marker expression. Genomic analysis. RRBS was performed as described 22 and bisulphite reads were aligned to the bisulphite-converted mm9 using Bismark 23 . Differentially methylated CpGs were identified using the Fisher exact test with Benjamini-Hochberg correction for multiple testing. We defined DMRs as regions containing at least five differentially methylated CpGs, where contiguous differentially methylated CpGs are separated by 250 bp or less, and for which the total methylation change between wild-type and Aid-null cells is 10% or more (calculated using all CpGs within the considered region including those that were not called as differentially methylated). The distribution of DMR lengths was as follows. For hypermethylated DMRs, average, 222 bp; median, 190 bp; minimum, 10 bp; maximum, 4,081 bp. For the lower number of hypomethylated DMRs, we observed the following statistics: average, 229 bp; median, 188 bp; minimum, 19 bp; maximum, 1,250 bp. Pairedend RNA-seq libraries were constructed as previously described 24 and sequenced using an Illumina HiSeq2000. Reads were aligned to mm9 using TopHat and gene expression levels were quantified using Cufflinks, using upper-quartile and GCcontent normalizations. Twofold changes with FPKM . 5 in at least one condition were used to derive differentially expressed genes. All statistical analyses were performed using the R software package. The meta-data for all RBBS data are provided in Supplementary Table 3 . Quantitative DNA methylation analysis by mass spectrometry. The level of DNA methylation for specific genes was measured using a MALDI-TOF mass spectrometry based method (EpiTYPER; Sequenom) as previously described 28 . Briefly, 1 mg of DNA was treated with sodium bisulphite using the EZ methylation kit (Zymo-Research). The treatment converts non-methylated cytosines into uracil, leaving methylated cytosines unchanged. PCR amplification, addition of SAP solution and Transcription/RNase A cocktails were performed according to the protocol provided by Sequenom and the mass spectra were quantified by the EpiTYPER analyser. Amplicons probed are given in Supplementary Table 2 .
